Sunshine Heart to Commence First-in-human Study Using Implantable Version of C-Pulse Technology in Q3 2016

By: via Benzinga
Sunshine Heart (NASDAQ: SSH) announced today an update on its next generation, fully implantable version of the Company's flagship ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.